Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder and vasomotor symptoms associated with menopause. As the synthetic form of… Read more









![Chemical structure of 4-[1-(1-Hydroxycyclohexyl)-2-(methylamino)ethyl]phenol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F135308-74-6-4-1-1-Hydroxycyclohexyl-2-methylaminoethylphenol.png&w=3840&q=75)
![Chemical structure of 5-(4-Hydroxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346601-55-5-5-4-Hydroxyphenyl-3-methyl-1-oxa-3-azaspiro5.5undecane.png&w=3840&q=75)
















Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder and vasomotor symptoms associated with menopause. As the synthetic form of the major active metabolite of venlafaxine, it requires rigorous monitoring to ensure product safety and efficacy. This category features a comprehensive selection of reference standards, including the active pharmaceutical ingredient, critical pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds essential for pharmaceutical analysis. Laboratories utilize these high-quality materials for precise impurity profiling, robust method validation, and accurate quantification during stability testing. Whether identifying specific degradation products, such as cyclic impurities or N-oxides, or employing labelled standards as internal controls in mass spectrometry, these compounds are vital for maintaining strict quality control and ensuring compliance with regulatory standards throughout the pharmaceutical development and manufacturing lifecycle.